Author ORCID Identifier

Ronan Lordan: 0000-0001-9668-3368

Halie M. Rando: 0000-0001-7688-1770

Casey S. Greene: 0000-0001-8713-9213

Simina M. Boca: 0000-0002-1400-3398

Christian Brueffer: 0000-0002-3826-0989

Stephen Capone: 0000-0001-7231-1535

Shikta Das: 0000-0002-8291-2788

Anna Ada Dattoli: 0000-0003-1462-831X

John J. Dziak: 0000-0003-0762-5495

Anthony Gitter: 0000-0002-5324-9833

Marouen Ben Guebila: 0000-0001-5934-966X

Nafisa M. Jadavji: 0000-0002-3557-7307

Likhitha Kolla: 0000-0002-1169-906X

Tiago Lubiana: 0000-0003-2473-2313

Adam L. MacLean: 0000-0003-0689-7907

David Manheim: 0000-0001-8599-8380

Dimitri Perrin: 0000-0002-4007-5256

Document Type

Article

Publication Date

5-1-2021

Publication Title

mSystems

Abstract

Coronavirus disease 2019 (COVID-19) has caused global disruption and a significant loss of life. Existing treatments that can be repurposed as prophylactic and therapeutic agents may reduce the pandemic’s devastation. Emerging evidence of potential applications in other therapeutic contexts has led to the investigation of dietary supplements and nutraceuticals for COVID-19. Such products include vitamin C, vitamin D, omega 3 polyunsaturated fatty acids, probiotics, and zinc, all of which are currently under clinical investigation. In this review, we critically appraise the evidence surrounding dietary supplements and nutraceuticals for the prophylaxis and treatment of COVID-19. Overall, further study is required before evidence-based recommendations can be formulated, but nutritional status plays a significant role in patient outcomes, and these products may help alleviate deficiencies. For example, evidence indicates that vitamin D deficiency may be associated with a greater incidence of infection and severity of COVID-19, suggesting that vitamin D supplementation may hold prophylactic or therapeutic value. A growing number of scientific organizations are now considering recommending vitamin D supplementation to those at high risk of COVID-19. Because research in vitamin D and other nutraceuticals and supplements is preliminary, here we evaluate the extent to which these nutraceutical and dietary supplements hold potential in the COVID-19 crisis. IMPORTANCE Sales of dietary supplements and nutraceuticals have increased during the pandemic due to their perceived “immune-boosting” effects. However, little is known about the efficacy of these dietary supplements and nutraceuticals against the novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) or the disease that it causes, CoV disease 2019 (COVID-19). This review provides a critical overview of the potential prophylactic and therapeutic value of various dietary supplements and nutraceuticals from the evidence available to date. These include vitamin C, vitamin D, and zinc, which are often perceived by the public as treating respiratory infections or supporting immune health. Consumers need to be aware of misinformation and false promises surrounding some supplements, which may be subject to limited regulation by authorities. However, considerably more research is required to determine whether dietary supplements and nutraceuticals exhibit prophylactic and therapeutic value against SARS-CoV-2 infection and COVID-19. This review provides perspective on which nutraceuticals and supplements are involved in biological processes that are relevant to recovery from or prevention of COVID-19.

Keywords

COVID-19, Nutraceuticals, Review, SARS-CoV-2, Vitamin D

Volume

6

Issue

3

DOI

10.1128/mSystems.00122-21

Comments

Archived as published.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.